Revolution Medicines Inc
NASDAQ:RVMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Revolution Medicines Inc
NASDAQ:RVMD
|
US |
|
Red River Bancshares Inc
NASDAQ:RRBI
|
US |
|
WiseTech Global Ltd
ASX:WTC
|
AU |
|
Vodafone Group PLC
LSE:VOD
|
UK |
|
Man Group PLC
LSE:EMG
|
UK |
|
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
UK |
|
Alaska Air Group Inc
NYSE:ALK
|
US |
|
Abionyx Pharma SA
PAR:ABNX
|
FR |
|
Eagle Eye Solutions Group PLC
LSE:EYE
|
UK |
|
Fomento Economico Mexicano SAB de CV
NYSE:FMX
|
MX |
|
Fission Uranium Corp
TSX:FCU
|
CA |
|
Monster Beverage Corp
NASDAQ:MNST
|
US |
|
Polski Koncern Naftowy Orlen SA
WSE:PKN
|
PL |
|
Elixirr International PLC
LSE:ELIX
|
UK |
|
Alps Alpine Co Ltd
TSE:6770
|
JP |
Shareholder Yield
Current shareholder yield for RVMD is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
RVMD Price
Revolution Medicines Inc
| Average Annual Return | 13.33% |
| Standard Deviation of Annual Returns | 32.99% |
| Max Drawdown | -58% |
| Market Capitalization | 30.3B USD |
| Shares Outstanding | 212 600 000 |
| Percentage of Shares Shorted | 5.5% |
